EUVIMEDEUVIMED entdecken
Crossref

Low-dose lipopolysaccharide modulates the RNF4-induced SUMO-dependent degradation of Nrf2 to mitigate oxidative stress in spinal cord injury

Weibing Liu, Kun Huang, Yuncheng Bai, Yayu Zhao, Wen Lei, Hongran Ge, Weichao Li

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-025-04375-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Weibing Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, The First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Spinal Cord Injuries, Oxidative Stress, Lipopolysaccharides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, the Young and Middle-aged Academic and Technical Leadership Reserve, Yunnan Spinal Cord Disease Clinical Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal cord injury (SCI) represents a significant medical challenge, with limited therapeutic options and suboptimal outcomes. This study investigates the therapeutic potential of low-dose lipopolysaccharide (LD-LPS) in SCI, aiming to elucidate the underlying molecular mechanisms. An in vivo SCI model was established, and the effects of LD-LPS, 2-D08, and RNF4 on nerve injury were assessed using Nissl staining, dihydroethidium (DHE) staining, and Basso, Beattie, Bresnahan (BBB) locomotor scores. In vitro models of SCI were also developed, treated with LD-LPS, and transfected with si-KEAP1, si-RNF4, or RNF4-overexpression vectors. RNF4 and Nrf2 expression levels were measured via immunofluorescence staining, reverse transcription quantitative polymerase chain reaction (RT-qPCR), and Western blot analysis. Cell viability and reactive oxygen species (ROS) production were assessed using the Cell Counting Kit-8 (CCK-8) and 2, 7-dichlorodihydrofluorescein diacetate (DCFH-DA) assays. Oxidative stress was evaluated by measuring the activities of catalase (CAT), superoxide dismutase (SOD), and glutathione (GSH). Immunoprecipitation was used to determine the SUMOylation level of SUMO-Nrf2, and the interaction between RNF4 and Nrf2 was analyzed through Split-BioID. LD-LPS demonstrated significant neuroprotective effects by mitigating oxidative stress following SCI. Mechanistically, RNF4 was identified as a critical regulator of Nrf2 SUMOylation, modulating its nuclear translocation. Genetic silencing of RNF4, in conjunction with LD-LPS treatment, alleviated SCI-induced neuronal damage, reduced oxidative stress, and promoted motor function recovery. Conversely, RNF4 overexpression exacerbated SCI injury, highlighting its central role in Nrf2 degradation. These results suggest that LD-LPS mitigates ROS production in SCI by modulating RNF4-mediated SUMOylation of Nrf2. These findings provide initial evidence for the molecular mechanisms underlying LD-LPS preconditioning in SCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2Spinal Cord InjuriesOxidative StressLipopolysaccharidesTranscription FactorsAnimalsMaleRats, Sprague-DawleyReactive Oxygen SpeciesRatsSumoylationMiceDisease Models, AnimalProteolysisHumans

Stichwörter der Autor:innen

LD-LPSNrf2ROSSCISUMOylation

Substanzen

NF-E2-Related Factor 2LipopolysaccharidesTranscription FactorsReactive Oxygen SpeciesNfe2l2 protein, ratNfe2l2 protein, mouse

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, The First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, No. 157, Jinbi Road, Kunming, 650032, China.
  • Faculty of Medical Science, Kunming University of Science and Technology, Kunming, 650500, China.
  • Yunnan Key Laboratory of Digital Orthopaedics, Kunming, 650032, China.
  • Department of Orthopedic Surgery, The First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, No. 157, Jinbi Road, Kunming, 650032, China. liweichao0394@126.com.
  • Faculty of Medical Science, Kunming University of Science and Technology, Kunming, 650500, China. liweichao0394@126.com.
  • Yunnan Key Laboratory of Digital Orthopaedics, Kunming, 650032, China. liweichao0394@126.com.

Förderung

  • the National Natural Science Foundation of China
  • the Young and Middle-aged Academic and Technical Leadership Reserve
  • Yunnan Spinal Cord Disease Clinical Medical Center
  • Yunnan Province High level Talent Support Program
  • the Key Research Project of Yunnan Provincial Science and Technology

Zitieren

APA

Liu, W., Huang, K., Bai, Y., Zhao, Y., Lei, W., Ge, H., & Li, W. (2026). Low-dose lipopolysaccharide modulates the RNF4-induced SUMO-dependent degradation of Nrf2 to mitigate oxidative stress in spinal cord injury. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04375-6

Vancouver

Liu W, Huang K, Bai Y, Zhao Y, Lei W, Ge H, et al. Low-dose lipopolysaccharide modulates the RNF4-induced SUMO-dependent degradation of Nrf2 to mitigate oxidative stress in spinal cord injury. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04375-6

BibTeX
@article{Liu2026,
  author = {Liu, Weibing and Huang, Kun and Bai, Yuncheng and Zhao, Yayu and Lei, Wen and Ge, Hongran and Li, Weichao},
  title = {Low-dose lipopolysaccharide modulates the RNF4-induced SUMO-dependent degradation of Nrf2 to mitigate oxidative stress in spinal cord injury},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-025-04375-6}
}
Kostenlos starten →